General Information of Drug (ID: DM197R2)

Drug Name
DNA-HIV-C/NYVAC-HIV-C
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Phase 1 [1]
Cross-matching ID
TTD ID
D08WFH

References

1 Clinical pipeline report, company report or official report of EuroVacc.